Who
Shanshan Xu
Director and Officer and 10% owner
Company insider
Files Form 4 as: Director and Officer and 10% owner, Bambusa Therapeutics.
In numbers
- Trades disclosed
- 10
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 29 Oct 2026
- Last trade
- 2 Nov 2026
- Last filed
- 2 Nov 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Nov 2026filed 2 Nov 2026 | BBTX Bambusa TherapeuticsBiotechnology | SEC FORM 4 Code C | —16,358 | filing |
| 2 Nov 2026filed 2 Nov 2026 | BBTX Bambusa TherapeuticsBiotechnology | SEC FORM 4 Code C | —147,238 | filing |
| 2 Nov 2026filed 2 Nov 2026 | BBTX Bambusa Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —4,155 at $0.00 | filing |
| 2 Nov 2026filed 2 Nov 2026 | BBTX Bambusa Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —10,450 at $0.00 | filing |
| 2 Nov 2026filed 2 Nov 2026 | BBTX Bambusa Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —1,753 at $0.00 | filing |
| 2 Nov 2026filed 2 Nov 2026 | BBTX Bambusa Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —37,399 at $0.00 | filing |
| 2 Nov 2026filed 2 Nov 2026 | BBTX Bambusa Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —94,050 at $0.00 | filing |
| 2 Nov 2026filed 2 Nov 2026 | BBTX Bambusa Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —15,789 at $0.00 | filing |
| 29 Oct 2026filed 2 Nov 2026 | BBTX Bambusa Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —379,102 at $0.00 | filing |
| 29 Oct 2026filed 2 Nov 2026 | BBTX Bambusa Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —758,204 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.